Dietary trans-vaccenic acid promotes anti-tumor immunity
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA835487 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR19091853_1.fastq.gz | Fastqsanger.gz | |||
| SRR19091853_2.fastq.gz | Fastqsanger.gz | |||
| SRR19091854_1.fastq.gz | Fastqsanger.gz | |||
| SRR19091854_2.fastq.gz | Fastqsanger.gz | |||
| SRR19091855_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 64 |
Similar Datasets
Project description:Dietary methionine restriction impairs anti-tumor immunity through gut microbiota
| PRJNA751076 | ENA
Project description:This SuperSeries is composed of the SubSeries listed below.
2023-09-22 | GSE202340 | GEO
Project description:Diet is believed to be an important mediator of oncogenesis and response to anti-cancer therapies, although, no evidence-based dietary guidelines exist for patients with cancer. Limiting protein intake can suppress tumor growth by both inducing nutrient stress and enhancing anti-tumor immunity. However, little is known about the impact of reducing dietary protein on the efficacy of standard anti-cancer therapies, including chemotherapy. Here, we present evidence that reducing protein intake in mice by 50% essentially stops the growth of established tumors, in parallel with inducing a stress response and DNA damage. Further, a reduced protein diet markedly enhances tumor regression upon treatment with 5-fluorouracil (5-FU), accompanied by elevated apoptosis and suppressed mitosis of tumor cells. Proteomic analysis of tumors from 5-FU treated mice fed control or reduced protein diets revealed marked changes including decreased abundance of proteins that mediate DNA repair and replication in mice given diet with reduced protein. In vitro studies mimicking amino acid changes found in tumors from reduced protein-fed mice revealed that cell viability and proliferation rates were similar irrespective of amino acid levels in medium, following 5-FU treatment. In contrast, cGAS-STING signaling, including transcription of Interferon beta 1, was maximally increased in 5-FU treated cells cultured in modified amino acid medium. These findings correlated with enhanced immune cell influx into tumors from mice fed reduced protein diet following 5-FU administration. Collectively, these findings suggest that reducing dietary protein in cancer patients may enhance the efficacy of chemotherapy, which may be mediated by anti-tumor immunity.
2025-03-07 | PXD052110 | Pride
Project description:Elaidic acid is an abundant industrial produced trans fatty acid in foodstuffs. Trans fatty acid intake has been correlated to an unfavorable plasma lipoprotein profile and an increased cardiovascular disease risk. The present study aimed to identify a plasma protein biomarker panel related to human intake of elaidic acid. The human liver cell line HepG2-SF was used as a model system, and the cells were maintained for seven days in serum-free medium containing 100 µM elaidic acid (trans∆9-C18:1), oleic acid (cis∆9-C18:1) or stearic acid (C18:0). The secretomes were analyzed by stable isotope labeling of amino acids in cell culture (SILAC), difference in gel electrophoresis (DIGE) and gene expression microarray analysis. Twelve proteins were found to be differentially regulated based on SILAC data (>1.3 fold change, P-value < 0.05), 13 proteins were found to be differentially regulated based on DIGE analysis (>1.3 fold change, P-value < 0.05), and 17 mRNA transcripts encoding extracellular proteins were determined to be affected (>1.3 fold change, P-value < 0.01) following the addition of elaidic acid compared to oleic acid or stearic acid. The results revealed that 37 proteins were regulated specifically in response to elaidic acid exposure, and nine of these proteins were confirmed to be regulated in this manner by using selected reaction monitoring mass spectrometry.
2011-11-30 | GSE34045 | GEO
Project description:Elaidic acid is an abundant industrial produced trans fatty acid in foodstuffs. Trans fatty acid intake has been correlated to an unfavorable plasma lipoprotein profile and an increased cardiovascular disease risk. The present study aimed to identify a plasma protein biomarker panel related to human intake of elaidic acid. The human liver cell line HepG2-SF was used as a model system, and the cells were maintained for seven days in serum-free medium containing 100 µM elaidic acid (trans∆9-C18:1), oleic acid (cis∆9-C18:1) or stearic acid (C18:0). The secretomes were analyzed by stable isotope labeling of amino acids in cell culture (SILAC), difference in gel electrophoresis (DIGE) and gene expression microarray analysis. Twelve proteins were found to be differentially regulated based on SILAC data (>1.3 fold change, P-value < 0.05), 13 proteins were found to be differentially regulated based on DIGE analysis (>1.3 fold change, P-value < 0.05), and 17 mRNA transcripts encoding extracellular proteins were determined to be affected (>1.3 fold change, P-value < 0.01) following the addition of elaidic acid compared to oleic acid or stearic acid. The results revealed that 37 proteins were regulated specifically in response to elaidic acid exposure, and nine of these proteins were confirmed to be regulated in this manner by using selected reaction monitoring mass spectrometry. HepG2 cells kept used in serum free conditions. The cells were incubated for seven days in either 100 µM oleic, elaidic or stearic acid, before total RNA was extracted. For each group four biological replicates were made and from the each RNA extraction two technical replicates were made. There is a control group without fatty acid incubation.
2011-11-30 | E-GEOD-34045 | biostudies-arrayexpress
Project description:Dietary restriction promotes anti-tumor immunity via T cell mediated ketone body metabolism
| PRJNA1109515 | ENA
Project description:PRMT1 suppresses anti-tumor immunity
| PRJNA840921 | ENA
Project description:Diet can shape immune function in vivo, but the molecular mechanism remains poorly defined. In this study, we investigated how a reduction in food intake (hereafter referred to as dietary restriction or DR) affects CD8+ T cell function in multiple models. We found that DR reduced tumor burden in mice in a CD8+ T cell-dependent manner, indicating that the anti-tumor effects of DR are mediated by the immune system. Consistent with this observation, DR increased CD8+ T cell effector function, including production of interferon-γ and granzyme B. Moreover, analysis of tumor infiltrating CD8+ T cells showed DR led to a decrease in markers of T cell exhaustion (PD1, TIM3, TOX) and an increase in markers of cell stemness (LY108, TCF1). In a model of Listeria infection, we further showed that DR enhances CD8+ T cell mitochondrial fitness and bioenergetic capacity, indicating that DR impacts both CD8+ T cell metabolism and effector function. Using stable isotope tracing, we identified that CD8+ T cells from mice on DR preferentially consumed the ketone body β-hydroxybutyrate (βOHB), which is elevated 3-fold in serum of in mice on DR relative to ad libitum-fed mice. Notably, the effects of DR on anti-tumor immunity were attenuated in conditional knockout mice in which T cells are unable to catabolize βOHB, supporting that DR enhances anti-tumor immunity, in part, through increasing βOHB availability and metabolism by T cells. Current and future studies are exploring the effects of DR on different immune cell populations within tumors to further delineate the mechanism(s) by which DR enhances the immune response in cancer.
2025-01-28 | GSE267070 | GEO
Project description:All-trans retinoic acid (ATRA) has been shown to have anti-proliferative effects, particularly in the context of cancer. However, the effects of ATRA on gene and microRNA expression in solid tumors have not been investigated. In this study, we performed gene expression and microRNA analysis of the squamous cell carcinoma cell line, ME180, following treatment with 10 micromolar all-trans retinoic acid (ATRA) for 1, 3, and 6 hours. Results provide insight into the temporal regulation of genes and microRNAs by retinoids.
2014-08-01 | GSE54464 | GEO
Project description:Dietary n-3 polyunsaturated fatty acids can reduce inflammation via a range of mechanisms. This study tested the effect of dietary eicosapentaenoic acid (EPA) on intestinal inflammation using interleukin-10 gene-deficient (Il10-/-) mice. Methods: At 35 days of age, 12 weaned Il10-/- and 12 C57 mice were randomly assigned to one of two modified AIN-76A diets, supplemented with 3.7% purified ethyl esters of either EPA (n-3) or oleic acid (OA, control). To identify genes relevant to colon inflammation, transcription profiling (microarrays and qRT-PCR) and bioinformatic analyses were used. Results: In this study, dietary EPA reversed the decrease in colon fatty acid β-oxidation gene expression observed in OA-fed Il10-/- compared to C57 mice. Il10-/- mice fed the OA diet showed decreased expression of antioxidant enzyme genes, as well as those involved in detoxification of xenobiotics, compared to C57 mice on the same diet. In contrast, dietary EPA increased the expression of these genes in Il10-/- mice. Conclusions: These data indicate that dietary EPA induced endogenous lipid oxidation which might have a potential anti-inflammatory effect on colon tissue. This is supported by the activation of the Ppara gene that regulates the expression of pro-inflammatory and immunomodulatory genes and proteins. Experiment Overall Design: The diet abbreviations EPA, OA, AA and CO used in the sample records Experiment Overall Design: refer to the following : Experiment Overall Design: CO : AIN-76A (control) Experiment Overall Design: OA : AIN-76A (fat-free) + 1% corn oil + 3.7% oleic acid Experiment Overall Design: EPA : AIN-76A (fat-free) + 1% corn oil + 3.7% eicosapentaenoic acid Experiment Overall Design: AA : AIN-76A (fat-free) + 1% corn oil + 3.7% arachidonic acid Experiment Overall Design: Corn oil was supplemented with purified linoleic and alpha-linolenic acid to meet the nutritional requirements of mice for these essential fatty acids. Diets fed for 6 weeks.
2008-10-21 | E-GEOD-12028 | biostudies-arrayexpress